111 related articles for article (PubMed ID: 16508195)
21. Regulation of the tyrosine kinase Itk by the peptidyl-prolyl isomerase cyclophilin A.
Brazin KN; Mallis RJ; Fulton DB; Andreotti AH
Proc Natl Acad Sci U S A; 2002 Feb; 99(4):1899-904. PubMed ID: 11830645
[TBL] [Abstract][Full Text] [Related]
22. Prolyl isomerase cyclophilin A regulation of Janus-activated kinase 2 and the progression of human breast cancer.
Zheng J; Koblinski JE; Dutson LV; Feeney YB; Clevenger CV
Cancer Res; 2008 Oct; 68(19):7769-78. PubMed ID: 18829531
[TBL] [Abstract][Full Text] [Related]
23. Cyclosporin A blocks muscle differentiation by inducing oxidative stress and inhibiting the peptidyl-prolyl-cis-trans isomerase activity of cyclophilin A: cyclophilin A protects myoblasts from cyclosporin A-induced cytotoxicity.
Hong F; Lee J; Song JW; Lee SJ; Ahn H; Cho JJ; Ha J; Kim SS
FASEB J; 2002 Oct; 16(12):1633-5. PubMed ID: 12207006
[TBL] [Abstract][Full Text] [Related]
24. The N-terminal cyclophilin-homologous domain of a 150-kilodalton tumor recognition molecule exhibits both peptidylprolyl cis-trans-isomerase and chaperone activities.
Rinfret A; Collins C; Ménard R; Anderson SK
Biochemistry; 1994 Feb; 33(7):1668-73. PubMed ID: 7906541
[TBL] [Abstract][Full Text] [Related]
25. Cyclosporin A-cyclophilin complex formation. A model based on X-ray and NMR data.
Spitzfaden C; Weber HP; Braun W; Kallen J; Wider G; Widmer H; Walkinshaw MD; Wüthrich K
FEBS Lett; 1992 Apr; 300(3):291-300. PubMed ID: 1555658
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization and refolding in vitro of a recombinant human cyclophilin A mutant: effect of a single Pro/Ser substitution on cyclophilin A structure and properties.
Xu LR; Yan X; Luo M; Guan YX; Yao SJ
Biotechnol Prog; 2008; 24(2):302-10. PubMed ID: 18333624
[TBL] [Abstract][Full Text] [Related]
27. Substrate-based design of reversible Pin1 inhibitors.
Zhang Y; Füssel S; Reimer U; Schutkowski M; Fischer G
Biochemistry; 2002 Oct; 41(39):11868-77. PubMed ID: 12269831
[TBL] [Abstract][Full Text] [Related]
28. Secondary structure and backbone resonance assignments of the periplasmic cyclophilin type peptidyl-prolyl isomerase from Escherichia coli.
Clubb RT; Thanabal V; Fejzo J; Ferguson SB; Zydowsky L; Baker CH; Walsh CT; Wagner G
Biochemistry; 1993 Jun; 32(25):6391-401. PubMed ID: 8518284
[TBL] [Abstract][Full Text] [Related]
29. Protein dynamics and enzymatic catalysis: investigating the peptidyl-prolyl cis-trans isomerization activity of cyclophilin A.
Agarwal PK; Geist A; Gorin A
Biochemistry; 2004 Aug; 43(33):10605-18. PubMed ID: 15311922
[TBL] [Abstract][Full Text] [Related]
30. The synthesis and evaluation of benzannelated-azatoxins: the benzazatoxins.
Miller TA; Vachaspati PR; Labroli MA; Thompson CD; Bulman AL; Macdonald TL
Bioorg Med Chem Lett; 1998 May; 8(9):1065-70. PubMed ID: 9871709
[TBL] [Abstract][Full Text] [Related]
31. Oxygen stress increases prolyl cis/trans isomerase activity and expression of cyclophilin 18 in rabbit blastocysts.
Santos AN; Körber S; Küllertz G; Fischer G; Fischer B
Biol Reprod; 2000 Jan; 62(1):1-7. PubMed ID: 10611060
[TBL] [Abstract][Full Text] [Related]
32. Pyrazolo[3,4-b]quinoxalines. A new class of cyclin-dependent kinases inhibitors.
Ortega MA; Montoya ME; Zarranz B; Jaso A; Aldana I; Leclerc S; Meijer L; Monge A
Bioorg Med Chem; 2002 Jul; 10(7):2177-84. PubMed ID: 11983514
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and biological evaluation of novel human Pin1 inhibitors with benzophenone skeleton.
Liu C; Jin J; Chen L; Zhou J; Chen X; Fu D; Song H; Xu B
Bioorg Med Chem; 2012 May; 20(9):2992-9. PubMed ID: 22459212
[TBL] [Abstract][Full Text] [Related]
34. Synthesis of the novel elemonic acid derivatives as Pin1 inhibitors.
Li X; Li L; Zhou Q; Zhang N; Zhang S; Zhao R; Liu D; Jing Y; Zhao L
Bioorg Med Chem Lett; 2014 Dec; 24(24):5612-5615. PubMed ID: 25466185
[TBL] [Abstract][Full Text] [Related]
35. A molecular dynamics study of Cyclophilin A free and in complex with the Ala-Pro dipeptide.
Mark P; Nilsson L
Eur Biophys J; 2007 Mar; 36(3):213-24. PubMed ID: 17225137
[TBL] [Abstract][Full Text] [Related]
36. [Recent advances in the study of pin1 and its inhibitors].
Zhang CJ; Zhang ZH; Xu BL; Wang YL
Yao Xue Xue Bao; 2008 Jan; 43(1):9-17. PubMed ID: 18357725
[TBL] [Abstract][Full Text] [Related]
37. Thermodynamics of cyclophilin catalyzed peptidyl-prolyl isomerization by NMR spectroscopy.
Videen JS; Stamnes MA; Hsu VL; Goodman M
Biopolymers; 1994 Feb; 34(2):171-5. PubMed ID: 8142586
[TBL] [Abstract][Full Text] [Related]
38. A protease-free assay for peptidyl prolyl cis/trans isomerases using standard peptide substrates.
Janowski B; Wöllner S; Schutkowski M; Fischer G
Anal Biochem; 1997 Oct; 252(2):299-307. PubMed ID: 9344417
[TBL] [Abstract][Full Text] [Related]
39. Structural and biochemical characterization of the cytosolic wheat cyclophilin TaCypA-1.
Sekhon SS; Kaur H; Dutta T; Singh K; Kumari S; Kang S; Park SG; Park BC; Jeong DG; Pareek A; Woo EJ; Singh P; Yoon TS
Acta Crystallogr D Biol Crystallogr; 2013 Apr; 69(Pt 4):555-63. PubMed ID: 23519664
[TBL] [Abstract][Full Text] [Related]
40. Peptidyl-prolyl-cis/trans-isomerase activity may be necessary for memory formation.
Bennett PC; Singaretnam LG; Zhao WQ; Lawen A; Ng KT
FEBS Lett; 1998 Jul; 431(3):386-90. PubMed ID: 9714548
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
